Ingeborg Ribsskog - Baron Adeler Malteserordenen E-post til slottet om Mette-Marit videoen Er noe galt i Martine-saken? Problemer med Grandiosa? johncons-MUSIKK johncons-REISE johncons-FOTBALL

Tuesday, 17 January 2017

Og enda enda enda enda mer om nettmobbing

Erik Ribsskog
Klage/Fwd: New Study Reinforces Importance of Implementing the National Action Plan for Adverse Drug Event Prevention
Erik Ribsskog Tue, Jan 17, 2017 at 11:38 AM
To: juridisk
Cc: health.gov@public.govdelivery.com
Hei,

dette er trakassering som følge av identitetstyveri, (virker det som).

(Jeg har ikke kontaktet disse).

Vennligst rydd opp!

Med hilsen

Erik Ribsskog

PS.

Jeg sender fortsatt om identitetstyveri til Datatilsynet, (siden at det ikke
virker helt klart, hvem andre jeg burde sende om dette til, synes
jeg).


---------- Forwarded message ----------
From: Health.gov
Date: Tue, Dec 20, 2016 at 3:54 PM
Subject: New Study Reinforces Importance of Implementing the National Action Plan for Adverse Drug Event Prevention
To: eribsskog@gmail.com


 health.gov Home of the Office of Disease Prevention and Health Promotion

New Study Reinforces Importance of Implementing the National Action Plan for Adverse Drug Event Prevention
12/19/2016 11:39 AM EST

A new study by the Centers for Disease Control and Prevention published in the Journal of the American Medical Association shows that, in 2013 and 2014, anticoagulants, diabetes agents, and opioid analgesics were among the most commonly implicated drug classes in emergency department visits for adverse drug events. Learn more



Please note: If you would like to continue receiving information about adverse drug events from the Office of Disease Prevention and Health Promotion, please sign up for updates from the Prevention Policy Matters blog.

Office of Disease Prevention and Health Promotion
1101 Wootton Parkway, Suite LL100  ·  Rockville, MD 20852
U.S. Department of Health and Human Services logo and Office of Disease Prevention and Health Promotion logo
This email was delivered to eribsskog@gmail.com.

To change your subscriptions or preferences or stop subscriptions anytime, log in to your User Profile with your e-mail address. For questions or problems with the service, please contact subscriberhelp.govdelivery.com for assistance.  All other inquiries can be directed to odphpinfo@hhs.gov.

This service is provided by the Office of Disease Prevention and Health Promotion.

No comments:

Post a Comment

Policy for kommentarer


Anonyme kommentarer, blir slettet, (etter en del problemer, med nettmobbing osv.).

Hvis du har et vanlig navn, så skriv gjerne noe, som skiller deg, fra andre, med samme navn, (sånn at det er klart, hvem som skriver).

Kommentarer som inneholder trakassering, (og som ikke holder seg, til temaet, i blogg-posten), blir bare slettet, (og ikke publisert).

Mvh.

Erik Ribsskog

PS.

For å eventuelt legge inn kommentar, så trykk på linken, til blogg-posten, (så kommer det opp et felt, hvor man kan kommentere).

Blog Archive